KalVista Pharmaceuticals (KALV) Short Interest Ratio & Short Volume $13.55 -0.05 (-0.37%) Closing price 04:00 PM EasternExtended Trading$13.70 +0.15 (+1.11%) As of 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KalVista Pharmaceuticals Short Interest DataKalVista Pharmaceuticals (KALV) has a short interest of 6.21 million shares, representing 14.04% of the float (the number of shares available for trading by the public). This marks a 5.97% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.2, indicating that it would take 11.2 days of the average trading volume of 409,172 shares to cover all short positions.Current Short Interest6,210,000 sharesPrevious Short Interest5,860,000 sharesChange Vs. Previous Month+5.97%Dollar Volume Sold Short$74.64 millionShort Interest Ratio11.2 Days to CoverLast Record DateApril 15, 2025Outstanding Shares49,716,000 sharesShort Percent of Float14.04%Today's Trading Volume520,715 sharesAverage Trading Volume409,172 sharesToday's Volume Vs. Average127% Short Selling KalVista Pharmaceuticals? Sign up to receive the latest short interest report for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKALV Short Interest Over TimeKALV Days to Cover Over TimeKALV Percentage of Float Shorted Over Time KalVista Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20256,210,000 shares $74.64 million +6.0%14.0%11.2 $12.02 3/31/20255,860,000 shares $67.62 million +0.3%13.2%11.2 $11.54 3/15/20255,840,000 shares $73.58 million +5.4%13.2%12.9 $12.60 2/28/20255,540,000 shares $63.16 million -5.0%12.5%13.3 $11.40 2/15/20255,830,000 shares $56.90 million -18.2%13.2%15.7 $9.76 1/31/20257,130,000 shares $63.53 million -6.1%N/A19.3 $8.91 1/15/20257,590,000 shares $59.66 million +1.9%N/A21 $7.86 12/31/20247,450,000 shares $63.10 million +3.8%N/A21.5 $8.47 12/15/20247,180,000 shares $62.39 million -1.1%N/A17.8 $8.69 11/30/20247,260,000 shares $73.04 million -1.5%N/A17.6 $10.06 Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/20247,370,000 shares $69.94 million +7.3%N/A17.7 $9.49 10/31/20246,870,000 shares $70.55 million +0.9%N/A19 $10.27 10/15/20246,810,000 shares $81.58 million +4.6%N/A20.1 $11.98 9/30/20246,510,000 shares $75.39 million +13.8%N/A17 $11.58 9/15/20245,720,000 shares $63.72 million +1.2%N/A15.6 $11.14 8/31/20245,650,000 shares $75.65 million -0.5%N/A17.4 $13.39 8/15/20245,680,000 shares $72.65 million -5.0%N/A17.9 $12.79 7/31/20245,980,000 shares $86.95 million -5.5%N/A18.3 $14.54 7/15/20246,330,000 shares $94.70 million +7.7%N/A18.4 $14.96 6/30/20245,880,000 shares $69.27 million +4.3%N/A17.7 $11.78 6/15/20245,640,000 shares $68.07 million +2.2%N/A15.4 $12.07 5/31/20245,520,000 shares $64.42 million -4.2%N/A14.1 $11.67 5/15/20245,760,000 shares $69.18 million +4.0%N/A11.7 $12.01 4/30/20245,540,000 shares $62.88 million -4.8%N/A7.4 $11.35 4/15/20245,820,000 shares $68.33 million +5.4%N/A7.3 $11.74 3/31/20245,520,000 shares $65.47 million +12.2%N/A6.8 $11.86 3/15/20244,920,000 shares $58.70 million +9.1%N/A6.4 $11.93 2/29/20244,510,000 shares $61.56 million +50.8%18.6%5.9 $13.65 2/15/20242,990,000 shares $44.13 million +21.1%12.4%4.4 $14.76 1/31/20242,470,000 shares $38.95 million -10.5%12.9%6.1 $15.77 1/15/20242,760,000 shares $35.77 million -25.2%14.2%8.3 $12.96 12/31/20233,690,000 shares $45.20 million +5.7%18.7%11.8 $12.25 12/15/20233,490,000 shares $37.27 million -9.6%16.7%10.8 $10.68 11/30/20233,860,000 shares $32.58 million -3.5%18.2%13.4 $8.44 11/15/20234,000,000 shares $30.76 million -3.4%19.0%13.9 $7.69 10/31/20234,140,000 shares $35.15 million -10.8%17.3%14.8 $8.49 10/15/20234,640,000 shares $42.13 million +4.7%N/A16.9 $9.08 9/30/20234,430,000 shares $42.66 million +9.1%N/A16.9 $9.63 9/15/20234,060,000 shares $39.87 million +4.6%N/A19.4 $9.82 8/31/20233,880,000 shares $42.10 million -5.4%N/A19.1 $10.85Trump Makes Major Crypto Announcement (Ad)Trump's Pro-Crypto Agenda Finally Sparks Market Recovery With Bitcoin surging past $90,000 and altcoins heating up, I'm seeing all the signs of a major market shift For a limited time, I'm revealing the name and complete analysis behind my top Trump-era crypto pick. Click here to check it out now 8/15/20234,100,000 shares $44.32 million +2.8%19.7%21.4 $10.81 7/31/20233,990,000 shares $40.30 million +2.3%18.3%21 $10.10 7/15/20233,900,000 shares $37.60 million +3.7%17.9%21 $9.64 6/30/20233,760,000 shares $33.84 million +0.8%17.3%18.5 $9.00 6/15/20233,730,000 shares $35.92 million +3.9%17.2%17.2 $9.63 5/31/20233,590,000 shares $35.00 million +5.0%16.5%14.6 $9.75 5/15/20233,420,000 shares $34.58 million +4.3%15.8%12.6 $10.11 4/30/20233,280,000 shares $27.98 million +17.1%14.0%11.5 $8.53 4/15/20232,800,000 shares $22.15 million +3.3%12.0%8.7 $7.91 3/31/20232,710,000 shares $21.30 million +10.2%11.6%8 $7.86 3/15/20232,460,000 shares $18.33 million +13.4%N/A7 $7.45 2/28/20232,170,000 shares $15.91 million -19.6%N/A6.3 $7.33 2/15/20232,700,000 shares $20.87 million -0.4%N/A8.6 $7.73 1/31/20232,710,000 shares $21.57 million +26.6%N/A8.9 $7.96 1/15/20232,140,000 shares $15.19 million -10.5%N/A6.7 $7.10 12/30/20222,390,000 shares $16.16 million +14.9%10.2%7.4 $6.76 12/15/20222,080,000 shares $11.90 million No Change10.4%4.7 $5.72 11/30/20222,080,000 shares $11.21 million No Change10.4%5.1 $5.39 11/15/20222,080,000 shares $10.86 million -8.8%10.4%5.1 $5.22 10/31/20222,280,000 shares $11.56 million -0.4%10.9%5.5 $5.07 10/15/20222,290,000 shares $10.44 million -10.2%10.9%6.2 $4.56 9/30/20222,550,000 shares $37.00 million +3.7%12.2%7.7 $14.51 9/15/20222,460,000 shares $36.43 million +4.7%11.8%13.2 $14.81 8/31/20222,350,000 shares $38.70 million +14.6%11.2%10.7 $16.47 8/15/20222,050,000 shares $32.41 million +8.5%9.8%7.3 $15.81 7/31/20221,890,000 shares $23.34 million +2.7%9.0%6.1 $12.35 7/15/20221,840,000 shares $22.69 million +3.4%8.7%5.7 $12.33 6/30/20221,780,000 shares $17.52 million -16.8%8.5%5.3 $9.84 6/15/20222,140,000 shares $19.07 million +58.5%10.2%6.4 $8.91 5/31/20221,350,000 shares $12.00 million +7.1%6.4%4.6 $8.89 5/15/20221,260,000 shares $12.23 million +37.7%6.0%5.4 $9.71 4/30/2022914,800 shares $11.65 million +4.6%4.3%4.4 $12.73 4/15/2022874,800 shares $12.56 million -19.7%4.2%4.2 $14.36 3/31/20221,090,000 shares $16.07 million -17.4%5.2%5.2 $14.74 3/15/20221,320,000 shares $19.14 million +1.5%6.3%6.6 $14.50 2/28/20221,300,000 shares $20.87 million +13.0%6.2%6.3 $16.05 2/15/20221,150,000 shares $18.95 million -5.7%5.5%5 $16.48 1/31/20221,220,000 shares $15.40 million +15.1%5.8%5.7 $12.62 1/15/20221,060,000 shares $13.29 million +11.9%5.0%5 $12.54 12/31/2021947,400 shares $12.53 million +0.4%4.5%4.7 $13.23 12/15/2021943,800 shares $12.81 million -2.2%4.2%4.4 $13.57 11/30/2021964,800 shares $13.99 million -6.3%4.3%4.4 $14.50 11/15/20211,030,000 shares $17.94 million -5.5%4.6%5.4 $17.42 10/29/20211,090,000 shares $19.60 million -11.4%4.9%5.8 $17.98 10/15/20211,230,000 shares $21.17 million +3.4%5.5%6.9 $17.21 9/30/20211,190,000 shares $20.77 million -14.4%5.4%6.5 $17.45 9/15/20211,390,000 shares $26.76 million -21.0%6.2%7 $19.25 8/31/20211,760,000 shares $35.97 million -4.9%7.9%8.7 $20.44 8/13/20211,850,000 shares $35.72 million -4.2%8.3%8.6 $19.31 7/30/20211,930,000 shares $38.87 million -1.5%9.5%8.5 $20.14Trump Makes Major Crypto Announcement (Ad)Trump's Pro-Crypto Agenda Finally Sparks Market Recovery With Bitcoin surging past $90,000 and altcoins heating up, I'm seeing all the signs of a major market shift For a limited time, I'm revealing the name and complete analysis behind my top Trump-era crypto pick. Click here to check it out now 7/15/20211,960,000 shares $43.04 million -2.0%9.9%7.7 $21.96 6/30/20212,000,000 shares $47.92 million +39.9%10.1%6.7 $23.96 6/15/20211,430,000 shares $40.78 million +3.6%7.2%4.6 $28.52 5/28/20211,380,000 shares $37.26 million -3.5%7.0%4.2 $27.00 5/14/20211,430,000 shares $35.91 million +6.7%N/A3.9 $25.11 4/30/20211,340,000 shares $33.81 million +3.1%N/A1.2 $25.23 4/15/20211,300,000 shares $32.40 million +10.2%N/A1.2 $24.92 3/31/20211,180,000 shares $30.33 million +51.8%N/A1.2 $25.70 3/15/2021777,400 shares $25.27 million -0.6%N/A0.8 $32.50 2/26/2021782,400 shares $25.99 million +22.0%N/A0.9 $33.22 2/12/2021641,100 shares $25.93 million +25.0%3.8%0.7 $40.45 1/29/2021513,100 shares $8.02 million +28.2%4.5%0.8 $15.64 1/15/2021400,200 shares $6.88 million +4.7%3.5%3.3 $17.18 12/31/2020382,400 shares $7.22 million +27.3%3.4%3.2 $18.89 12/15/2020300,300 shares $5.69 million -11.6%2.7%3 $18.95 11/30/2020339,700 shares $6.61 million +3.9%3.0%3.8 $19.47 11/15/2020326,900 shares $6.15 million +47.0%2.8%3.8 $18.80 10/30/2020222,400 shares $3.83 million -12.3%1.9%2.9 $17.22 10/15/2020253,600 shares $3.79 million +2.3%2.2%3.7 $14.95 9/30/2020247,900 shares $3.12 million -16.4%2.1%3.8 $12.59 9/15/2020296,600 shares $4.12 million -7.1%2.5%3.4 $13.88 8/31/2020319,100 shares $4.18 million -10.6%2.7%2.6 $13.10 8/14/2020356,900 shares $4.53 million -9.2%2.8%2.8 $12.70 7/31/2020392,900 shares $3.86 million -8.7%3.1%2.9 $9.83 7/15/2020430,200 shares $4.97 million +9.8%3.4%3.2 $11.56 6/30/2020391,800 shares $4.74 million +24.2%3.1%2.8 $12.10 6/15/2020315,500 shares $3.28 million -7.5%2.5%2.3 $10.40 5/29/2020341,200 shares $3.71 million +1.2%2.7%2.6 $10.86 5/15/2020337,200 shares $3.42 million -2.7%2.7%2.3 $10.15 KALV Short Interest - Frequently Asked Questions What is KalVista Pharmaceuticals' current short interest? Short interest is the volume of KalVista Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 6,210,000 shares of KALV short. 14.04% of KalVista Pharmaceuticals' shares are currently sold short. Learn More on KalVista Pharmaceuticals' current short interest. What is a good short interest ratio for KalVista Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KALV shares currently have a short interest ratio of 11.0. Learn More on KalVista Pharmaceuticals's short interest ratio. Which institutional investors are shorting KalVista Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of KalVista Pharmaceuticals: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for KalVista Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.04% of KalVista Pharmaceuticals' floating shares are currently sold short. Is KalVista Pharmaceuticals' short interest increasing or decreasing? KalVista Pharmaceuticals saw a increase in short interest in April. As of April 15th, there was short interest totaling 6,210,000 shares, an increase of 6.0% from the previous total of 5,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does KalVista Pharmaceuticals' short interest compare to its competitors? 14.04% of KalVista Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to KalVista Pharmaceuticals: MoonLake Immunotherapeutics (12.52%), ACADIA Pharmaceuticals Inc. (12.84%), Alvotech (0.73%), Twist Bioscience Co. (16.82%), Amneal Pharmaceuticals, Inc. (3.56%), Denali Therapeutics Inc. (10.34%), Recursion Pharmaceuticals, Inc. (30.90%), Apellis Pharmaceuticals, Inc. (23.14%), ImmunityBio, Inc. (58.08%), Biohaven Ltd. (9.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short KalVista Pharmaceuticals stock? Short selling KALV is an investing strategy that aims to generate trading profit from KalVista Pharmaceuticals as its price is falling. KALV shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against KalVista Pharmaceuticals? A short squeeze for KalVista Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KALV, which in turn drives the price of the stock up even further. How often is KalVista Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALV, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies MLTX Short Squeeze ACAD Short Squeeze ALVO Short Squeeze TWST Short Squeeze AMRX Short Squeeze DNLI Short Squeeze RXRX Short Squeeze APLS Short Squeeze IBRX Short Squeeze BHVN Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KALV) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KALV Stock Free KALV Stock Alerts